Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. [electronic resource]
Producer: 20070809Description: 533-41 p. digitalISSN:- 1592-8721
- Acute Disease
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antilymphocyte Serum -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Diseases -- chemically induced
- Clinical Trials as Topic -- statistics & numerical data
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Graft vs Leukemia Effect
- Hematopoietic Stem Cell Transplantation -- mortality
- Humans
- Leukemia, Myeloid -- drug therapy
- Lymphocyte Depletion
- Male
- Middle Aged
- Recurrence
- Remission Induction
- Survival Analysis
- T-Lymphocytes
- Time Factors
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Treatment Outcome
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.